Ozempic face: real side effect or celebrity myth?

What did @dr.khandzhyan actually say?

Honestly, this is a hard video to fact-check cleanly. The transcript is largely incoherent, likely the result of poor auto-translation from Russian or Armenian, given the hashtags and apparent language of the original. What we can piece together is that the creator, who presents as a dermatologist, is discussing "ozempic face" in the context of Olivia Wilde and rapid weight loss on GLP-1 medications. The phrase "asambic facem" appears to be a transliteration of "ozempic face." Beyond that, specific medical claims are nearly impossible to extract from this transcript with confidence.

What the hashtags and framing tell us is the video is positioned around the cosmetic side effects of semaglutide-driven weight loss, specifically facial volume loss and accelerated skin aging. That's a legitimate dermatological topic. Whether the creator handled it responsibly is harder to assess without a clean translation.

Does the science back this up?

The core concept being discussed, facial fat loss during rapid weight reduction on GLP-1 agonists, is real and documented. It's not a myth invented by tabloids. Fat redistribution and volume loss in the face during significant weight loss is well-established in dermatology literature, and GLP-1 medications accelerate this process due to the speed and degree of weight loss they produce.

A 2023 commentary in JAMA Facial Plastic Surgery (Rohrich et al.) drew attention to the clinical reality of facial aging associated with rapid weight loss on semaglutide. The mechanism is straightforward: subcutaneous facial fat provides structural support. Lose it fast, lose it for good. The skin, especially in patients over 40, does not bounce back proportionally. Collagen synthesis slows with age, and rapid fat loss leaves skin without the scaffolding it relied on. This is not unique to Ozempic, but the scale and speed of weight loss GLP-1 drugs produce has made it more visible as a phenomenon.

What did they get wrong (or right)?

Without a clean transcript, assigning specific errors to this creator feels unfair. What we can say is that the broader framing around "ozempic face" is medically grounded. Dermatologists are legitimately seeing patients who have lost significant facial volume on semaglutide or tirzepatide and are seeking filler, fat grafting, or other interventions.

What often goes wrong in this genre of content is the implication that ozempic face is a reason to avoid GLP-1 medications, or that the cosmetic downside outweighs the metabolic benefits. For someone with obesity, type 2 diabetes, or cardiovascular risk, that framing is potentially harmful. The cardiovascular benefits of semaglutide demonstrated in the SELECT trial (Lincoff et al., 2023, NEJM) are substantial. Facial volume loss is a manageable cosmetic issue. It is not a reason to stop a medication that reduces major cardiac events by 20 percent.

If the creator made claims suggesting patients should avoid these drugs due to cosmetic effects, that would be worth pushing back on. Based on the available transcript fragments, we cannot confirm or deny that framing was used here.

What should you actually know?

"Ozempic face" is real, but it is not caused by semaglutide directly. It is caused by weight loss, the same weight loss that improves blood sugar, blood pressure, and cardiovascular outcomes. The face just shows it faster than people expect because facial fat is metabolically active and responds to caloric deficit.

Dermatologically, patients on GLP-1 medications benefit from early conversations about skincare, sun protection, collagen-supporting nutrition (adequate protein, vitamin C), and realistic expectations about skin laxity. Procedures like hyaluronic acid fillers, poly-L-lactic acid, or autologous fat transfer are options, but they are elective. No intervention is required. The medication doing its job is not a side effect in the clinical sense. It is the mechanism.

Anyone making medical decisions about starting or stopping a GLP-1 medication based on a TikTok video about a celebrity's face should talk to a prescribing clinician first.